🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Can Elon buy Cigna and run that into the ground too please?

If #Ticketmaster was a bartender

christopher plys Oskar Eriksson WOW!!!

Natashia Mueller is an Ithaca Public Schools senior with a special #GivingTuesday story. She puts together chemo care packages every year and delivers them to patients at the UW Health | Carbone Cancer Center:

Another pragmatic trial by VA Cooperative Studies Program. Great work all around! Veterans Affairs VA Research

Ringler helped launch "My Life, My Story," a program that’s spread to 85 hospitals. Ten years later, he tells how the veterans he’s interviewed changed him. captimes.com/news/for-thor-…

Congratulations to PSTP graduate David Kosoff for being awarded the Jr. Faculty Excellence in Research Mentoring Award from University of Wisconsin Department of Medicine! #PSTPatUW

After discussion on gamma-delta T cells effector function #targets23-- Johnathan Ebben MD, PhD @CapitiniMD turn them against PanCAN restoring starved TME by LXR4 antagonism. University of Wisconsin Department of Medicine UW Health | Carbone Cancer Center

Today, the Veterans Affairs announced that the Million Veteran Program (MVP) welcomed the one millionth Veteran into the program, the first research program in the world to include extensive health and genetic data for this many participants. #VAResearch research.va.gov/currents/1123-…

One of the most important findings relating to MRD at #ASH23: In an older transplant-ineligible patient population, an intensive quaduplet regimen with dara/carf/len/dex had the "highest" MRD negativity rates... But the lowest survival at 18 months! shorturl.at/sFUV0

🔥Today in Annals of Int Med: We show Axi-cel & Liso-cel are NOT COST-EFFECTIVE in our decision analysis of second-line CAR-T therapies for Diffuse Large B-Cell Lymphoma, and calculate the economic impact to be >$6.8 billion over 5 years! 🧵👇 acpjournals.org/doi/10.7326/M2…

*Simple* things (get-up-and-go and self-reported performance status) predict toxicity in older pts with DLBCL. Nice work by Pallawi Torka and the team Memorial Sloan Kettering Cancer Center. Hoping to learn even more about the utility of geriatric assessments in SWOG Cancer Research Network S1918.

@revhowardarson Wisconsin regularly wins an amount of awards comparable to "the entire nation of France" at international cheese competitions prnewswire.com/news-releases/…

Dr. Jeremy Kratz, a physician-scientist has received more than $1 million in grant funding to investigate a new targeted therapy to improve treatments for patients diagnosed with cholangiocarcinoma. #CancerResearch uwhealth.org/news/refining-…

Tune in to our new episode on quadruplets in newly diagnosed transplant-ineligible #Myeloma with Timothy Schmidt, MD! 🎙️ We break down the IMROZ & BENEFIT trials and how to apply them in our current practice. 🩺🔍 share.transistor.fm/s/6e20d230 Check out this short clip!

Study led by Rahul Banerjee, MD, FACP showed that Dexamethasone dose reductions did not impact PFS or OS in newly diagnosed multiple myeloma in multivariate analyses in a secondary real world analysis. ashpublications.org/blood/article-…

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Mini-CHOP in age 80+ from LYSA trials Hervé Tilly #ASH24: - 269 pts, mFU 12 y - mPFS 2.4 y, mOS 4.1 y, 5-yr PFS 38%, OS 44% - most common COD: lymphoma (36%), TRM 5% - ⬇️TRM during tx after institution of prephase Great long-term data in older DLBCL. Prephase ftw! #lymsm #gerionc

What if this was a drug ?🙂 🆕 NEJM | June 2025 🎯 CHALLENGE Trial: Structured exercise after adjuvant chemo in colon cancer 📦 RCT | n=889 | Median FU: 7.9 yrs 🟠 3-yr structured aerobic program vs health ed alone 📈 Primary Endpoint: Disease-Free Survival (DFS) 🔹 HR 0.72